Ole E. Sorensen

Ole E. Sorensen

Auto-generated profile, based on publicly available information

Ole E. Sorensen

Division of Infection Medicine, Department of Clinical Sciences Lund, Lund University, Lund, Sweden

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2001 in Blood
Verified
Journal Article
Closed access
PDF file
OSOle E. Sørensen
Ole E. Sørensen
PFPer Follin
Per Follin
AJAnders H. Johnsen
Anders H. Johnsen
JCJero Calafat
Jero Calafat
GTG. Sandra Tjabringa
G. Sandra Tjabringa
NBNiels Borregaard
Niels Borregaard
Cathelicidins are a family of antimicrobial proteins found in the peroxidase-negative granules of neutrophils. The known biologic functions reside in the C-terminus, which must be cleaved from the holoprotein to become active. Bovine and porcine cathelicidins are cleaved by elastase from the azurophil granules to yield the active antimicrobial peptides. The aim of this study was to identify the physiological setting for cleavage of the only human cathelicidin, hCAP-18, to liberate the antibacterial and cytotoxic peptide LL-37 and to identify the protease responsible for this cleavage. Immunoelectron microscopy demonstrated that both hCAP-18 and azurophil granule proteins were present in the phagolysosome. Immunoblotting revealed no detectable cleavage of hCAP-18 in cells after phagocytosis. In contrast, hCAP-18 was cleaved to generate LL-37 in exocytosed material. Of the 3 known serine proteases from azurophil granules, proteinase 3 was solely responsible for cleavage of hCAP-18 after exocytosis. This is the first detailed study describing the generation of a human antimicrobial peptide from a promicrobicidal protein, and it demonstrates that the generation of active antimicrobial peptides from common proproteins occurs differently in related species.

1 August 2007 in Trends in Immunology
Verified
Journal Article
Closed access
NBNiels Borregaard
Niels Borregaard
OSOle E. Sørensen
Ole E. Sørensen
KTKim Theilgaard-Mönch
Kim Theilgaard-Mönch

2 May 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
OSOle E. Sørensen
Ole E. Sørensen
NBNiels Borregaard
Niels Borregaard
Neutrophil extracellular traps (NETs) were discovered as extracellular strands of decondensed DNA in complex with histones and granule proteins, which were expelled from dying neutrophils to ensnare and kill microbes. NETs are formed during infection in vivo by mechanisms different from those originally described in vitro. Citrullination of histones by peptidyl arginine deiminase 4 (PAD4) is central for NET formation in vivo. NETs may spur formation of autoantibodies and may also serve as scaffolds for thrombosis, thereby providing a link among infection, autoimmunity, and thrombosis. In this review, we present the mechanisms by which NETs are formed and discuss the physiological and pathophysiological consequences of NET formation. We conclude that NETs may be of more importance in autoimmunity and thrombosis than in innate immune defense.

1 March 2003 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JHJohan D. Heilborn
Johan D. Heilborn
MNMargareta Frohm Nilsson
Margareta Frohm Nilsson
OSOle Sørensen
Ole Sørensen
MSMona Ståhle-Bäckdahl
Mona Ståhle-Bäckdahl
GKGunnar Kratz
Gunnar Kratz
NBNiels Borregaard
Niels Borregaard

1 June 2007 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AMAdrian R. Martineau
Adrian R. Martineau
Katalin A WilkinsonKatalin A Wilkinson
Katalin A Wilkinson
SNSandra M. Newton
Sandra M. Newton
RFR. Andres Floto
R. Andres Floto
ANAnthony W. Norman
Anthony W. Norman
RWRobert J. Wilkinson
Robert J. Wilkinson
Vitamin D deficiency is associated with susceptibility to tuberculosis, and its biologically active metabolite, 1α,25 dihydroxyvitamin D3 (1α,25(OH)2D3), has pleiotropic immune effects. The mechanisms by which 1α,25(OH)2D3 protects against tuberculosis are incompletely understood. 1α,25(OH)2D3 reduced the growth of mycobacteria in infected human PBMC cultures in a dose-dependent fashion. Coculture with agonists or antagonists of the membrane or nuclear vitamin D receptors indicated that these effects were primarily mediated by the nuclear vitamin D receptors. 1α,25(OH)2D3 reduced transcription and secretion of protective IFN-γ, IL-12p40, and TNF in infected PBMC and macrophages, indicating that 1α,25(OH)2D3 does not mediate protection via these cytokines. Although NOS2A was up-regulated by 1α,25(OH)2D3, inhibition of NO formation marginally affected the suppressive effect of 1α,25(OH)2D3 on bacillus Calmette Guérin in infected cells. By contrast, 1α,25(OH)2D3 strongly up-regulated the cathelicidin hCAP-18 gene, and some hCAP-18 polypeptide colocalized with CD14 in 1α,25(OH)2D3 stimulated PBMC, although no detectable LL-37 peptide was found in supernatants from similar 1α,25(OH)2D3-stimulated PBMC cultures. A total of 200 μg/ml of the active peptide LL-37, in turn, reduced the growth of Mycobacterium tuberculosis in culture by 75.7%. These findings suggest that vitamin D contributes to protection against TB by “nonclassical” mechanisms that include the induction of antimicrobial peptides.

15 December 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
GTG. Sandra Tjabringa
G. Sandra Tjabringa
JAJamil Aarbiou
Jamil Aarbiou
DNDennis K. Ninaber
Dennis K. Ninaber
JDJan Wouter Drijfhout
Jan Wouter Drijfhout
OSOle E Sørensen
Ole E Sørensen
PHPieter Hiemstra
Pieter Hiemstra
Antimicrobial peptides produced by epithelial cells and neutrophils represent essential elements of innate immunity, and include the defensin and cathelicidin family of antimicrobial polypeptides. The human cathelicidin cationic antimicrobial protein-18 is an antimicrobial peptide precursor predominantly expressed in neutrophils, and its active peptide LL-37 is released from the precursor through the action of neutrophil serine proteinases. LL-37 has been shown to display antimicrobial activity against a broad spectrum of microorganisms, to neutralize LPS bioactivity, and to chemoattract neutrophils, monocytes, mast cells, and T cells. In this study we show that LL-37 activates airway epithelial cells as demonstrated by activation of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) and increased release of IL-8. Epithelial cell activation was inhibited by the MAPK/ERK kinase (MEK) inhibitors PD98059 and U0126, by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478, by blocking anti-EGFR and anti-EGFR-ligand Abs, and by the metalloproteinase inhibitor GM6001. These data suggest that LL-37 transactivates the EGFR via metalloproteinase-mediated cleavage of membrane-anchored EGFR-ligands. LL-37 may thus constitute one of the mediators by which neutrophils regulate epithelial cell activity in the lung.